RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Cash from financing

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024-983+38.26%
Dec 31, 2023-711-55.13%
Dec 31, 2022-1,584+344.71%
Dec 31, 2021-356-26.82%
Dec 31, 2020-487+321.19%
Dec 31, 2019-116-89.50%
Dec 31, 2018-1,101+132.71%
Dec 31, 2017-473+76.24%
Dec 31, 2016-268+69.29%
Dec 31, 2015-159+3.66%
Dec 31, 2014-153-538.40%
Dec 31, 201335-122.43%
Dec 31, 2012-156+15.09%
Dec 31, 2011-135+30.13%
Dec 31, 2010-104

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)